Park I, Lee JL, Lee S-HL. Axitinib for recurrent or metastatic non-clear cell renal cell carcinoma. EMUC 2017, P105.
Omalizumab vermindert jeuk gerelateerd aan checkpointremmers en anti-HER2-therapieën
jun 2021 | Borstkanker, Immuuntherapie, Longoncologie, Uro-oncologie